FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Targets

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
228
FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Targets Leadership Position in Multi-Billion Dollar Green Ammonia Industry with $7.5 Million Private Placement

- FuelPositive recently announced a non-brokered private placement to raise up to $7.5 million, which is active now
- According to the company, net proceeds from the placement will be directed toward further development of demonstration systems for its on-site green ammonia production systems as well as working capital requirements
- As of early May, commissioning of the first farm-ready demonstration unit was nearing completion, with the company having kicked off production of its first commercial systems
- FuelPositive will deliver the demonstration system to a farm in Manitoba, Canada, and expects to gather real-time usage data that will shape future systems being built concurrently with the initial demonstration system

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a green technology company committed to developing commercially viable and sustainable onsite containerized green ammonia production systems, announced plans to raise up to $7.5 million by way of a non-brokered private placement. The net proceeds from this placement, the company said, will be channeled toward further development of demonstration systems for its green ammonia production solution, general working capital, and payment of services provided to FuelPositive in the ordinary course of business (https://nnw.fm/8xSZr ).

“We anticipate that the enhanced liquidity resulting from this offering will contribute to greater growth for the company. The company’s pioneering green ammonia technology and decentralized business model hold immense potential to reshape the ammonia industry, fostering a greener future for generations to come. The net proceeds from this financing will help ensure FuelPositive’s leadership and ‘first-mover’ position in the multi-billion dollar sustainable and green ammonia industry,” said Ian Clifford, FuelPositive’s Board Chair and CEO.

The placement will consist of up to 115,384,615 units of the company, each priced at $0.065. Each unit comprises one common share of the company and one common share purchase warrant, allowing holders to purchase an additional common share at an exercise price of $0.09 within 36 months following the closing date of the placement. If the volume-weighted average closing price of FuelPositive’s common shares on the TSX Venture Exchange exceeds $0.40 for ten consecutive trading days, FuelPositive may choose to accelerate the expiry date of the warrants to 30 days after a public announcement of the election.

According to Clifford, the placement incorporates the newly implemented Listed Issuer Financing Exemption (“LIFE”), allowing both accredited and non-accredited investors to participate equally in the company’s financings. FuelPositive also announced that the securities issued in the placement pursuant to LIFE would not be subject to a hold period per Canadian securities law, while all other securities would be subject to a statutory hold period of four months and one day following issuance.

The upcoming placement is expected to support FuelPositive’s efforts to revolutionize the green ammonia industry by commercializing production solutions to produce green ammonia when and where it’s needed. Already, the company has begun running the final commissioning of the first farm-ready demonstration system, a production unit capable of producing300 kg per day of green anhydrous ammonia or a little over 100 metric tons per year, according to a May 2 news release (https://nnw.fm/MURfH ). Aptly named the FP300 model, this system is set to be delivered to the 11,000-acre crop farm of Tracy and Curtis Hiebert, where it will be heavily monitored for a full year, with the results shaping future systems being built concurrently with the initial demonstration system.

FuelPositive’s partnership with the Hieberts also includes a provision that may see the company piloting up to three versions of the demonstration systems on the farm (https://nnw.fm/3vGAw ). The planned financing will, therefore, be integral in helping the company achieve this and other targets.

In addition to reporting that the final commissioning is underway, FuelPositive also announced it had started production of its first commercial systems. Having successfully met its planned pre-sales capacity of 30 units, the company plans to deliver the first batch of FP300 commercial systems beginning in 2024.

FuelPositive also announced its latest model, the FP1500, a turnkey system that upsizes the daily output of green anhydrous ammonia to 1,500 kg. or 500 metric tons per year. According to the company, the decision to offer this larger system was influenced by customer demand from its pre-sales campaign. “Multiple end-users in various sectors, including farms of 10,000+ acres, have indicated the immediate need of FuelPositive systems of this scale and configuration. The FP1500 will answer this larger scale, onsite need,” explained Clifford.

For more information, visit the company’s website at www.FuelPositive.com.

NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://nnw.fm/NHHHF

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

FuelPositive Corp (NHHHF) Stock Research Links

NHHHF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LIV Golf's Big Play: Restructuring with Saudi PIF

Updated Category News Views 6

Trailblazing Change in the Golf World It's like watching a high-stakes game of chess where pieces are worth billions. White Knight Capital Corp. has thrown its hat into the ring with the Public Investment Fund of Saudi Arabia to overhaul LIV Golf Enterprises. This isn't your average Monday morning golf chat; it's full-on corporate drama with financial steroids. Debt Swap...

Continue Reading
Innovative SOV Launches for Offshore Wind Revolution

Updated Category News Views 2

A New Era for Offshore Wind Operations Mark my words, folks, this launch ain't just some minor milestone swaying gently on the industry seas. ZPMC's 'Wind of Ocean' is about to kickstart a whole new game in Europe's offshore wind space. Built with brains and brawn, this vessel embodies the future of sustainable and efficient offshore operations. The announcement from...

Continue Reading
MiniTool MovieMaker 8.9: Keyframe Animation Upgrade

Updated Category News Views 2

Breaking Down MiniTool MovieMaker 8.9's Revamp Kicking off the day with some noteworthy news in the creative software arena, MiniTool's latest update to its MovieMaker program is grabbing attention. It’s not often you hear software developers hitting the right balance between functionality and simplicity as they've done with this release. Keyframe Animation: The Star of...

Continue Reading
Fujifilm's New 400mm Lens: A Game Changer?

Updated Category News Views 1

Big Moves from Fujifilm's Camp Now we're talking, Fujifilm! Just when you think they might ease off the throttle, they crank up the heat with the XF 400mm f/4.5 R LM OIS WR lens. This isn’t just your run-of-the-mill update. It's a significant addition to their already beefed-up lineup for sports and wildlife. You know what that means: more reach, less baggage. Compact...

Continue Reading
Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Updated Category News Views 1

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...

Continue Reading
Clinical Trials Services Market Set for Big Growth

Updated Category News Views 2

Eyeing a Market Surge in Clinical Trials Numbers don't lie, and they're painting a promising picture for the clinical trials services market with a solid 8% growth forecasted annually till 2031. From a modest $66.20 billion in 2026, we're looking at ballooning to a hefty $97.41 billion by 2031. What’s cooking? Let me dish it out for you. Key Drivers and Dynamics North...

Continue Reading
Potomac Edison Eyes Rate Hike for System Overhaul

Updated Category News Views 0

FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...

Continue Reading
Pathlock Faces Identity Governance Opportunities in 2026

Updated Category News Views 3

Challenges in Identity Governance Emerge for 2026 Imagine a world where digital identities run wild—unmonitored, orphaned, dormant. Welcome to 2026, where identity governance and administration (IGA) face a reckoning, dragging enterprises into the spotlight as they scramble to protect against identity chaos. With Pathlock’s recent recognition in the Gartner Market...

Continue Reading
Reolink Unveils OMVI 2i Ultra at IFA 2026

Updated Category News Views 6

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Continue Reading
China's Diplomatic Dance: SCO Summit & Key Visits

Updated Category News Views 2

A Diplomatic Balancing Act Xi Jinping's recent diplomatic tour, climaxing at the Shanghai Cooperation Organization (SCO) Summit and extending through critical visits to Kyrgyzstan and Egypt, paints a compelling picture of China's strategic intentions. For those of us watching the geopolitical chessboard, it's like seeing a master strategist at work—pondering a tricky...

Continue Reading

Top 5 Most Recently Viewed Articles

Theravance Buyout Scrutinized: Is Zymeworks Deal Fair?

Updated Category News Views 6

Theravance and Zymeworks: What's the Deal? First things first, the numbers. Theravance Biopharma, the biotech entity waving its NASDAQ: TBPH ticker, is about to jump into bed with Zymeworks, another player in the pharma game. The pitch? One hundred seventy-six bucks a share in cold, hard cash, plus a contingent value right. That's right—sweet on paper, but always worth...

Continue Reading
Top Stock Split Opportunities for Maximum Growth Potential

Updated Category News Views 72

Stock splits surged back into the limelight recently, flipping the script on a strategy that had been gathering dust. Once thought outdated, these moves have become hot again, reflecting how companies with robust performances can maintain investor interest while managing share prices effectively. When you see a stock split, it’s often more than just a number game; it's...

Continue Reading
Roc Nation and Musicow: Pioneering a New Era in Music Equity

Updated Category News Views 455

Roc Nation Collaborates with Musicow for Music Equity Innovation Roc Nation has embarked on an exciting partnership with Musicow, a South Korean fintech firm. This collaboration aims to introduce the first Music Equity Service Provider (MESP) in the United States. By allowing music rights holders to buy, sell, and trade shares in music royalty revenue, this initiative...

Continue Reading
Latest Updates from the FDA: New Guidelines and Approvals

Updated Category News Views 396

Insights from Recent FDA Activities The U.S. Food and Drug Administration (FDA) has released an overview of recent important developments aimed at enhancing public health and safety. These updates offer invaluable information about various health issues, product approvals, and guidance to manufacturers. Investigation of E. coli Outbreak Recently, the FDA updated its...

Continue Reading
Insider Sale Sparks Interest in BorgWarner's Future Prospects

Updated Category News Views 173

Understanding Insider Transactions at BorgWarner Recently, a notable insider sale captured attention. Isabelle McKenzie, the Vice President of BorgWarner, made headlines when she sold 2,500 shares, totaling around $100,025. This transaction was officially reported in a filing to the SEC, particularly through a Form 4. Such insider activities often spark curiosity among...

Continue Reading